Showing results (131-140 of 225) with videos related to
Sort By:
Pageof 23
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenograftsDanny L Costantini, Kristin McLarty, Helen Lee, et al.International Journal of Cancer|February 11, 2005
LAF-4 is aberrantly expressed in human breast cancerMinh D To, Stephanie A Faseruk, Nalan Gokgoz, et al.Breast Cancer Research : BCR|September 24, 2011
A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosisDong-Yu Wang, Susan J Done, David R McCready, et al.Marine Pollution Bulletin|October 4, 2016
Excess seawater nutrients, enlarged algal symbiont densities and bleaching sensitive reef locations: 2. A regional-scale predictive model for the Great Barrier Reef, AustraliaScott A Wooldridge, Scott F Heron, Jon E Brodie, et al.International Forum of Allergy & Rhinology|December 14, 2019
Virtual coach: the next tool in functional endoscopic sinus surgery educationJohn P Richards, Aaron J Done, Samuel R Barber, et al.Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|January 24, 2022
Annual Mammographic Screening Reduces the Risk of Interval or Higher Stage Invasive Breast Cancers Among Postmenopausal Women in the Ontario Breast Screening ProgramKristina M Blackmore, Anna M Chiarelli, Lucia Mirea, et al.ISRN Oncology|April 25, 2012
Comparison of whole genome amplification methods for analysis of DNA extracted from microdissected early breast lesions in formalin-fixed paraffin-embedded tissueNona Arneson, Juan Moreno, Vladimir Iakovlev, et al.Schizophrenia Research|October 21, 2009
Beyond symptom dimensions: schizophrenia risk factors for patient groups derived by latent class analysisS J Leask, J K Vermunt, D J Done, et al.Breast Cancer Research and Treatment|June 28, 2012
¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancerAisha Fasih, Humphrey Fonge, Zhongli Cai, et al.BMJ (Clinical Research Ed.)|June 29, 1991
Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sampleD J Done, E C Johnstone, C D Frith, et al.Pageof 23